Bayer strikes deal to buy Schiff Nutrition
date:Oct 31, 2012
growth with strategic bolt-on acquisitions. This transaction represents an excellent strategic fit for our HealthCare business, said Dr Marijn Dekkers, Bayer AGs chief executive.

The Schiff business significantly enhances our presence and position in the United States, which accounts for more over-the-counter and nutritional products sales than any other country in the world.

We are focused on building premium brands and leading innovation. We believe Bayer is well positioned to take our lead
2/3 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/26 15:06